Anat Loewenstein, MD

home / authors / anat-loewenstein-md-mha

Articles

ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy

ARVO 2025: Anat Loewenstein, MD, and colleagues on meeting needs of patients with diabetic retinopathy

Martin David Harp;Hattie Hayes;Anat Loewenstein, MD

May 5th 2025

Prof Loewenstein and a cohort of colleagues assessed the current treatment outlook for patients with diabetic retinopathy

An image of boxing gloves in a ring, hanging over an open flame. ©Image by Jennifer Toomey / MJH Life Sciences using AI

Up for debate: Clinicians take on hot topics at the Congress on Controversies in Ophthalmology

Hattie Hayes;Anat Loewenstein, MD;Baruch Kuppermann, MD, PhD

March 31st 2025

This year, the COPHy meeting moves beyond retina, addressing uveitis, neuro-ophthalmology and glaucoma in Seville, Spain

Sun rays stretch over the horizon as a sun rises or sets against a blue sky. Image credit: ©Pavlo Vakhrushev – stock.adobe.com

Experts say revakinagene taroretcel-lwey approval may represent dawn of new treatments for neurodegenerative conditions

Sheryl Stevenson;Anat Loewenstein, MD;Rishi P. Singh, MD;Martin Friedlander, MD, PhD;Mohammad Rafieetary, OD, FAAO

March 10th 2025

Clinicians react to the US approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for macular telangiectasia type 2

Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT

Angiogenesis 2025: The global forecast for AI-driven home OCT

Sheryl Stevenson;Hattie Hayes;Anat Loewenstein, MD

February 19th 2025

Professor Anat Loewenstein, MD, speaks about her presentation from the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting

A line drawing of a human heart with an eye enclosed in its chambers. Image credit: ©croisy – stock.adobe.com

Listening to the heart: Lessons from cardiology in remote monitoring and AI

Anat Loewenstein, MD

February 14th 2024

Physicians explore how other specialties adopt and integrate remote monitoring

Assessing barriers to retinal care during a pandemic

Dr Amir Rosenblatt;Dr Livia Faes;Anat Loewenstein, MD

November 2nd 2022

A global survey of retinal experts assessed their perceptions of evolving clinical practice in the Covid-19 era, focusing on digital teleophthalmology, home monitoring and decentralised patient care.

Ang-2/VEGF-A Inhibition Synergistic Effect in DME and AMD

Anat Loewenstein, MD

March 22nd 2021

Anat Loewenstein, MD, MHA, explores dual Ang-2/VEGF-A inhibition in the management of diabetic macular edema and exudative age-related macular degeneration.

Angiogenesis 2021 Virtual Symposium Takeaways & Final Thoughts

Anat Loewenstein, MD

March 22nd 2021

Angiogenesis, Exudation, and Degeneration 2021 Virtual Symposium highlights and thoughts on current treatments options for DME and exudative AMD are discussed.